UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): March 18, 2022
SURGEPAYS, INC.
(Exact name of Registrant as specified in its charter)
| Nevada | | 001-40992 | | 98-0550352 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
3124 Brother Blvd, Suite 104
Bartlett, TN 38133
(Address of principal executive offices, including zip code)
901-302-9587
(Registrant’s telephone number, including area code)
Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock | | SURG | | The Nasdaq Stock Market LLC |
| Common Stock Purchase Warrants | | SURGW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Anthony P. Nuzzo, Jr., the President of SurgePays, Inc. (the “Company”), a member of the Company’s Board of Directors, and the Chief Executive Officer of LogicsIQ, Inc., a subsidiary of which the Company owns over 90%, died suddenly on March 18, 2022.
“Our entire company mourns this terrible loss. Our deepest sympathies and sincere condolences go out to Anthony’s family. Anthony will be greatly missed,” said Kevin Brian Cox, the Company’s Chief Executive Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | SURGEPAYS, INC. |
| | |
| Date: March 24, 2022 | By: | /s/ Kevin Brian Cox |
| | Name: | Kevin Brian Cox |
| | Title: | Chief Executive Officer |
